Abstract
Immune hemolytic anemia and reactivated tuberculosis developed in a patient treated with α-interferon for Kaposi's sarcoma and splenic non-Hodgkin's lymphoma. The hemolytic process stopped on cessation of interferon and initiation of corticosteroid therapy, and the Coomb's test became negative. The possibility of reactivation of tuberculosis by interferon is discussed.
| Original language | English |
|---|---|
| Pages (from-to) | 445-448+503 |
| Journal | Harefuah |
| Volume | 127 |
| Issue number | 11 |
| State | Published - 1 Jan 1994 |
ASJC Scopus subject areas
- General Medicine
